Hehehe....We have reviewed the annual reports of ANS and also the history of ANS in 2017 and 2018. So we are not blind but know the facts. Why did WAPRC buy ANS at 0.013 and not at premium?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025